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Abstract
Purpose: This work aims to study the generalizability of a pre-developed deep learning (DL) dose prediction model for volu-
metric modulated arc therapy (VMAT) for prostate cancer and to adapt the model, via transfer learning with minimal input data, to
three different internal treatment planning styles and one external institution planning style.
Methods: We built the source model with planning data from 108 patients previously treated with VMAT for prostate cancer.
For the transfer learning, we selected patient cases planned with three different styles, 14-29 cases per style, in the same institution
and 20 cases treated in a different institution to adapt the source model to four target models in total. We compared the dose
distributions predicted by the source model and the target models with the corresponding clinical dose predictions used for patient
treatments and quantified the improvement in the prediction quality for the target models over the source model using the Dice
similarity coefficients (DSC) of 10% to 100% isodose volumes and the dose-volume-histogram (DVH) parameters of the planning
target volume and the organs-at-risk.
Results: The source model accurately predicts dose distributions for plans generated in the same source style, but performs
sub-optimally for the three different internal and one external target styles, with the mean DSC ranging between 0.81-0.94 and
0.82-0.91 for the internal and the external styles, respectively. With transfer learning, the target model predictions improved the
mean DSC to 0.88-0.95 and 0.92-0.96 for the internal and the external styles, respectively. Target model predictions significantly
improved the accuracy of the DVH parameter predictions to within 1.6%.
Conclusion: We demonstrated the problem of model generalizability for DL-based dose prediction and the feasibility of using
transfer learning to solve this problem. With 14-29 cases per style, we successfully adapted the source model into several different
practice styles. This indicates a realistic way forward to widespread clinical implementation of DL-based dose prediction.
1. Introduction
Radiation therapy treatment planning is a complex process,
as the target dose prescription and normal tissue sparing are
conflicting objectives. The lowest achievable dose for each in-
dividual organ-at-risk (OAR) is unknown a priori. Multiple it-
erations between the planner and the physician may be required
to reach the optimal balance between target coverage and OAR
sparing. Recent planning tool developments have focused on
improving the efficiency of the planning iteration process. In-
teractive multi-criteria optimization (MCO) allows the planner
or the physician to explore the trade offs among the possible
solutions and eliminates the communication lag in the plan iter-
ation process [1–5]. Knowledge-based planning (KBP) takes a
data-driven approach to learn from the past high-quality clinical
plans and predicts a patient’s specific dose-volume histogram
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(DVH) and OAR dose constraints for new patients by using the
relationship between geometric and dosimetric information de-
rived from historical patient plans in the library [6–13].
Advancements in the field of artificial intelligence (AI), es-
pecially in data-driven machine learning (ML) and deep learn-
ing (DL) algorithms for many challenging computer vision prob-
lems, have inspired many researchers in radiation oncology.
Deep learning and, more specifically, convolutional neural net-
work (CNN) architectures have significantly improved imaging
and vision tasks. In particular, UNet [14], a complex archi-
tecture initially designed for biomedical image segmentation,
has notably improved the performance of predicting the radia-
tion dose distribution in the body without going through a real
planning process [15–18]. The predicted dose distribution pro-
vides both visual input and DVH metrics to assist physician’s
trade-off decision-making up front to provide more achievable
planning objectives prior to the planning process.
While DL models holds promise as accurate predictors of
the expected dose distribution prior to planning, the heterogene-
ity of data is a common challenge for AI modeling. Despite
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nationally-accepted practice guidelines that set the baseline of
patient care, actual clinical practice is rarely clearly defined in
black and white. Patient-specific medical reasons such as hip
prosthesis and previous radiation can lead to deviation from the
guideline. Strategies for solving a specific dosimetric trade-
off problem will vary among different physicians and planners
[19].
Treatment planning systems and optimization algorithms
also introduce variations into clinical practice. Plans generated
by different practice styles that meet the national guidelines,
in terms of plan quality, can end up with different spatial dose
distributions. A DL dose prediction model built based on a par-
ticular dataset from one institution may not work well for differ-
ent treatment planning styles even within the same institution.
Therefore, the ability to adapt a pre-built DL dose prediction
model to a given planning/practice style is desirable.
Furthermore, expertise in AI modeling is not widely acces-
sible in various clinical settings in the field of radiation on-
cology. Although some AI solutions are commercially avail-
able and the vendor provides AI expertise, building an initial
model still requires a clean and large dataset of treated pa-
tient cases. This requires a tremendous effort from the user
to collect and curate enough data for modeling. Sharing mod-
els between institutions could alleviate the challenges associ-
ated with building an initial AI model, but the heterogeneity in
practice mentioned above would still yield unsatisfactory per-
formance. Thus, the ability to easily adapt a pre-built dose pre-
diction model to a different practice style could lead to practical
clinical implementation of DL dose prediction models in real-
world clinical settings.
The goals of this work are to investigate the problem of
generalizing DL-based dose prediction models and to utilize
transfer learning to adapt a DL prostate VMAT dose prediction
model to various planning/practice styles with minimal data
from each individual style. We built a source model based on
the 108 patients treated with VMAT for prostate cancer in a
large institution.This work tests two types of practice hetero-
geneity: first, different planning styles in the same institution
where we built the source model; and second, planning prac-
tices at a different institution. The source model was adapted
to three internal planning styles and one external planning style
with 14-29 training cases for each model. To our knowledge,
this is the first work to study the DL-based dose prediction
model generalizability problem and to utilize transfer learning
to provide a practical solution.
2. Methods
2.1. Data Groups
For this study, we selected a total of 248 cases of prostate
cancer treated with the VMAT technique. 188 cases from one
institution, planned with the Eclipse treatment planning system
(TPS) utilizing the progressive resolution optimizer for VMAT
optimization; and the 60 cases from an external institution, planned
with the Erasmus-iCycle TPS [20], a system for automated multi-
criteria treatment planning. Table 1 summarizes the datasets
and shows the dose distributions of individual styles.
The source model was trained with the ”Source” dataset,
which consists of 108 plans in the conformal dose style, which
is the most representative style of planning in our institution. In
the same institution, we found three additional planning styles
for prostate cancer VMAT treatments, represented by three tar-
get datasets: ”Internal-A,” ”Internal-B,” and ”Internal-C”. The
Internal-A and Internal-B styles are slightly more aggressive in
OAR sparing than the ”Source” style. The Internal-C style is
a more extreme approach that allows a higher dose to femoral
heads to spare the bladder and rectum. We use these three target
datasets to demonstrate the problem of model generalizability
and to test the feasibility of using a small dataset for transfer
learning by using 14-29 cases from each target dataset. We use
2-5 test cases to evaluate the target model’s performance.
The ”External” style represents plans from a different in-
stitution. As one can see, the dose distribution of the External
style has many intermediate dose spikes in both the lateral and
the anterior directions. Given the large differences between the
External and the Source styles, we trained the target model with
20 cases and thoroughly evaluated it with 40 cases.
Dose Style Name Dataset Training Testing
Source 118 108 10
Internal-A 34 29 5
Internal-B 16 14 2
Internal-C 20 17 3
External 60 20 40
Table 1: Patient datasets used for building the source model (Source) and for
testing the model generalizability and then for adapting model (Internal-A,
Internal-B, Internal-C, and External). First column shows a typical dose dis-
tribution of the planning style represented by each dataset.
2.2. Network
In this work, we implemented a 3D UNet for the model ar-
chitecture, [14], as UNet has been extensively used in radiation
therapy for dose prediction [15–18]. The inputs to this archi-
tecture are the contours of the planning target volume (PTV)
and OARs, including bladder, rectum, left and right femoral
heads, and body, which were formatted as binary masks with
a size of [120 × 120 × 64] each. Due to the memory limits of
a 16 GB GPU (NVIDIA K80), we implemented patch-based
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training, with a patch size of [96 × 96 × 48]. At each train-
ing iteration, the patches were randomly selected from the bi-
nary mask data based on a Gaussian sampling scheme proposed
by [21]. We also implemented group normalization [22] after
each set of convolution and rectified linear unit (ReLU) oper-
ations, which helps accelerate the convergence rate in the net-
work. This model is trained to learn the mapping between the
binary masks of the OARs and the clinical radiation dose dis-
tribution in the body. Mean Square Error (MSE) was the loss
function, and the Adam optimizer with a learning rate of 10−4
was used to minimize the MSE. The final network consists of
85 layers with 7,870,177 trainable parameters.
2.3. Transfer learning
For both the internal Source dataset and the external institu-
tion dataset, the transfer learning method implemented for style
transfer involves 3 components: 1) freezing the weights of the
first half of the model, 2) training only the second half of the
model, and 3) randomly reinitializing the weights of the very
last layer of the model. Assuming that the major variations in
dose distributions are owing to different planning styles across
institutions, we can effectively freeze the first half of the UNet,
which finds features from just the anatomy. We can then train
just the second half of the network to learn the dose distribu-
tions of a different planning style. Finally, to assist the network
in converging and to prevent it from falling into a local mini-
mum, we reinitialize the weights in the final layer of the net-
work. The hyperparameters remain unchanged, except for the
learning rate, which was reduced to one-tenth of the original
value.
2.4. Model Evaluation
We first applied the Source model to the Source test cases to
evaluate the model’s performance on its own planning style. We
then applied the Source model to the test cases of the three inter-
nal and one external target styles to investigate the model’s per-
formance on other planning styles and to set the baseline predic-
tion quality before transfer learning. Individual target models
trained via transfer learning were each applied to the test cases
of their own planning style to investigate the prediction qual-
ity after adapting the Source model to the given target style.
To further evaluate the improvement achieved by the transfer
learning, we cross-compared each of the doses predicted by the
Source and target models with the respective clinical plan dose.
We compared the absolute doses predicted by the DL mod-
els to the clinical plan doses without further normalization. We
evaluated the spatial dose distributions and the dose-volume
histograms (DVH). We calculated DVH metrics including struc-
ture mean and maximum doses (i.e. D2), PTV D98, and PTV
D95. The clinical plan dose served as the baseline for the dose
comparison. We calculated the differences in the DVH metrics
between the clinical plan dose and the predicted doses to quan-
tify the DVH agreement. In addition, we calculated the dice
similarity coefficients (DSC), 2(A∩B)(A+B) , for isodose volumes from
10% to 100% of the prescribed dose to quantify the agreement
of the spatial dose distribution between the clinical plan dose
and the predicted doses. We used a paired t-test to calculate
the statistical significance of the results for the External style,
which had enough test cases for a meaningful test.
3. Results
Figure 1 shows a typical example of the dose agreement be-
tween the clinical plan and the Source model prediction for the
Source style test cases. Upon visually inspecting the dose distri-
bution and the DVH, one can see that the Source model predicts
the PTV dose correctly with minimal differences in the OAR
doses. The violin plots present the differences in the PTV and
the OAR DVH metrics between the clinical plan and the Source
model prediction. The differences in the PTV DVH metrics are
mostly within 3%, as reflected by the width of the individual
data clusters. The median of the PTV dose differences are all
within 2%. Similarly, the median of the mean and maximum
OAR dose differences are within 1% and 2%, respectively.
Figure 2 illustrates the Source model and target model pre-
dictions on the test cases of individual target styles. The im-
provement in the model performance after transfer learning can
be seen in the dose comparisons among the clinical plan, the
Source model prediction and the target model prediction. The
Source model fails to predict the style-specific dose distribu-
tion features. However, the target models have learned those
dose distribution features via transfer learning, so they predict
a distribution similar to the clinical plan and exhibit a better
agreement in the DVH, especially for the Internal-C and Exter-
nal styles.
We compared each of the Source and target model predic-
tions to the respective clinical plan dose and calculated the DSC
of individual isodose volumes accordingly. The DSC values in-
creased with the dose agreement with a coefficient of 1 consid-
ered to be a perfect match. As presented in Figure 3, the target
models improved upon the Source model in term of DSC re-
gardless of the planning style. However, the Internal and the
External styles exhibit different trends. For the Internal styles,
both the Source and the target models predict the high dose
bath (70% to 100%) fairly well. The main improvements ap-
pear in the intermediate dose bath (60% to 30%). The mean
DSC ranges between 0.81-0.94 for the three Source models and
between 0.82-0.91 for the corresponding target models. The
largest improvement may be seen in the Internal-C style, as
the target model achieves a 7% improvement over the Source
model (mean DSC is 0.80 for the Source model and 0.87 for
the Internal-C target model) transfer learning. For the External
style, the target model improves significantly upon the Source
model throughout all isodose volumes (p < 0.05), with the im-
provement increasing as the isodose volume decreases. An av-
erage of 5% and 8% mean DSC improvements were achieved
in the high and the intermediate dose volumes, respectively. A
systematic 10% improvement was seen in the low dose volume.
Figure 4 illustrates the Source and the External target model
performances on predicting the DVH metric of the External
style test cases. Overall, as indicated by the length of the data
clusters, the Source model demonstrates a large variation in
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Figure 1: Performance analysis of the source model including the dose distributions with the structure contours outlined in white dotted lines; the DVH of the
clinical plan (solid lines) and the predicted dose (dotted lines)l and the violin plots of the target and the OAR DVH metrics.
Figure 2: Dose comparison between the clinical plan and the predicted plan using the source and the target models including the dose distributions and the DVH
comparisons.
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Figure 3: Dice similarity coefficients analysis,
(
2(A∩B)
A+B
)
. Comparing the isodose volumes between the clinically planned dose and the predicted dose. One standard
deviation represented the error in the graphs.
the prediction quality, while the External target model demon-
strates more consistent and accurate predictions. The Source
model overestimates the PTV doses, especially for the Dmean
and the D2. The External target model significantly improved
the predictions and resulted in mean differences within 1.6%
(Table 2). In terms of the OAR dose predictions, the target
model achieved an agreement within 1.5%. In summary, the
External target model improved upon the Source model by up
to 6.4% and 6.0% in the PTV and the OAR DVH predictions,
respectively (p < 0.05).
4. Discussion and Conclusion
There has been growing attention on leveraging AI-based
decision support tools (DST) to improve the treatment planning
process. Incorporating AI DST as a part of the clinical path-
way [1] could standardize evidence-based practices to ensure
high quality and cost-effective medical care. AI algorithms,
including the DL dose prediction model in this work, require
large repositories of high quality data. This becomes one of
the barriers to widespread deployment of AI-based solutions in
the radiation oncology field. In this study, we utilized transfer
learning to solve the data size problem and demonstrated the
ability to adapt a source model to three different internal plan-
ning styles and one external planning style with minimal data
input.
Heterogeneity in clinical practices, whether intra- or inter-
institutional, is commonly seen. The clinical protocols and
guidelines set the floor of treatment plan acceptance, but users
Table 2: Quantitative performance evaluation based on the error in target model
dose prediction vs the source model dose prediction. Error is calculated in
respect to the clinically planned dose for the external data.
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Figure 4: Quantitative performance evaluation of the error in the DVH metric in target model dose prediction vs the source model dose prediction in respect to the
clinically planned dose for the external data.
† Represents p < 0.05
set the ceiling for their own practice. Table 1 clearly shows
that, even within the same institution, the individual trade-off
preferences of different physicians and planners in combination
result in a variety of dose distribution styles. On top of these
differences in practice, the different treatment planning system
employed in the External institution in this study yielded dra-
matically different dose distributions from the Source style. The
treatment plans in the Source style were optimized with a spe-
cific objective function (normal tissue objective, NTO) to shape
the dose fall-off conformally, whereas plans from the External
institution were optimized with a unique 23-beam starting con-
dition of the VMAT optimization that led to distinct spikes in
the low dose bath. Regardless of the dose distribution style,
they are all clinically accepted plans that comply with the clin-
ical guideline. The AI models adaptation to the users practice
style can achieve standardization with respect to the user’s prior
experience. This would be practical and beneficial for imple-
menting AI-guided planning in practice, because the user can
precisely interpret the predicted dose for meaningful clinical
use.
Directly deploying a model built in a different practice style
may lead to unsatisfactory predictions. As shown in the Source
model predictions on the cases planned with target styles in Fig-
ure 2, the predicted doses inherit the conformal dose distribu-
tion of the Source style. They meet the planning objectives,
but they fail to represent the dose distribution features of the
target styles. This reflects a common frustration of institutions
that are trying to clinically implement a model provided by a
vendor or developed by a different institution. In this work,
we demonstrated the transfer learning can adapt a source model
into various practice styles.
Transfer learning with an additional 14-29 cases in the tar-
get style, allowed the target models to learn the features of the
new planning style quickly. Taking the External style as an ex-
ample, the distinct low dose spikes were precisely predicted by
the External target model. We saw this improvement globally
in all target styles, and it increased as the variation between the
Source and target styles increased (Figure 2). For example, the
Internal-A and Internal-B styles pull the dose from the rectum
only slightly more aggressively than the Source style, so the in-
herent differences are small. Therefore, the Source model still
achieved more than a 0.78 mean DSC, which the target mod-
els only slightly outperformed. In contrast, the Internal-C style
turns off the NTO and intentionally trades femur doses for lower
rectum and bladder doses, so it differs more substantially from
the Source style. Accordingly, the Source model predictions on
the Internal-C style cases demonstrated a significant dip in DSC
in the intermediate dose levels, but the Internal-C target model
improved the DSC to a satisfactory level. For the External style,
which is fundamentally different from the Source style, the Ex-
ternal target model improved upon the Source models DSC by
up to 10% DSC and had a DSC higher than 0.87 among all test
cases and isodose volumes.
The intermediate dose bath of the VMAT plan is more un-
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predictable because of its complex nature. The variations in
trade-offs and planning approaches can tremendously polarize
the spatial dose distribution in this dose range. Moreover, with
the large numbers of beam angles in VMAT optimization, the
optimizer has more options to pull the dose off a specific area,
which makes the dose more uncertain to predict. Traditionally,
the DL dose predictor has a hard time handling these style-
specific features. This is reflected in figure 3, which shows
that the DSC of the Source model prediction ranges between
0.80-0.94. However, with transfer learning, the target models
can represent these dose features, and the DSC of target model
prediction increased to 0.87-0.99, which is satisfactory.
In light of the barriers to accessing the expertise of AI mod-
eling, collecting sufficient data to train a model, and sharing
data among institutions, a broad AI tool that can easily adapt
a maturely built model to different practice styles could allow
more practices to access and clinically implement an AI model
for dose prediction. We used prostate VMAT as an example
to demonstrate the feasibility of leveraging transfer learning for
model adaptation. However, this methodology can be employed
for other AI tools in the field of radiation oncology and allow
for widespread application of such tools.
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